Skip to main content

. 1992 Jul;36(7):1585. doi: 10.1128/aac.36.7.1585-a

Ticarcillin-clavulanic acid dosing ratio for treatment of experimental Staphylococcus aureus endocarditis.

PMCID: PMC191629 PMID: 1510459

1585

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Catherall E. J., Gillon V., Hurn S., Irwin R., Mizen L. Efficacy of ticarcillin-clavulanic acid for treatment of experimental Staphylococcus aureus endocarditis in rats. Antimicrob Agents Chemother. 1992 Feb;36(2):458–462. doi: 10.1128/aac.36.2.458. [DOI] [PMC free article] [PubMed] [Google Scholar]
Scully B. E., Chin N. X., Neu H. C. Pharmacology of ticarcillin combined with clavulanic acid in humans. Am J Med. 1985 Nov 29;79(5B):39–43. doi: 10.1016/0002-9343(85)90127-5. [DOI] [PubMed] [Google Scholar]
Tasker T. C., Cockburn A., Jackson D., Mellows G., White D. Safety of ticarcillin disodium/potassium clavulanate. J Antimicrob Chemother. 1986 May;17 (Suppl 100):225–232. doi: 10.1093/jac/17.suppl_c.225. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES